Telangana: Aurobindo Pharma has announced that the Company will be investing Rs.10.40 crores to acquire 26 percent equity and ...

Six leading pharmaceutical companies, Sun Pharmaceutical Industries, Ipca Laboratories, Indoco Remedies, Aurobindo Pharma, ...

Meanwhile, earnings before interest, tax, depreciation, and amortisation (EBITDA) surged multifold to ₹128 crore, reflecting ...

Quarterly Net Profit at Rs. 845.81 crore in December 2024 down 9.66% from Rs. 936.29 crore in December 2023. EBITDA stands at ...

AM(IST)on Friday in an upbeat market. Torrent Pharmaceuticals Ltd.(up 1.67 per cent), Aurobindo Pharma Ltd.(up 1.22 per cent) ...

Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...

Hyderabad: Degrowth in its US formulations business dragged down Aurobindo Pharma's consolidated net profits for the third ...

Aurobindo Pharma's net profit declines 10% due to lower U.S. formulations revenue, but revenue from operations increases.

Aurobindo Pharma reported a 10% YoY decline in net profit to Rs 846 crore for Q3FY25, mainly due to a decrease in US sales.

Aurobindo Pharma's net profit fell 10% to Rs 846 crore in Q3 FY25, while revenue rose to Rs 7,979 crore. The company attributes this to volume growth and new launches.